In this edition of Trial Better, Deborah Collyar, an oncology patient advocate, discusses the importance of patient advocacy in clinical trials and her own personal advocacy in oncology. Learn more about the role of a patient advocate and the long-term benefits of keeping the patients and their needs at the center of clinical trials.

ERT’s Brian Smith and AliveCor’s Dr. David Albert explore how technological advancements can not only offer solutions to problems caused by COVID-19, but change the landscape of clinical research even after the pandemic is over.

ERT’s Jason Eger, Nadeeka Dias, and Chris Watson explore technology-based solutions for the challenges of vaccine trials and address the biggest issue facing the clinical research community today: COVID-19.

Nick Conn of Heart Health Intelligence and Jean-Philippe Couderc of VPG Medical join Trial Better for an expanded discussion of new passive health monitoring technologies, including how new devices can pass regulatory scrutiny and the impact they’ll have on patients in clinical trials

ATS and ERS have updated their guidance for pulmonary function testing in both healthcare and clinical research in October 2019 for the first time since 2005. Kevin McCarthy from ERT, a member of the ATS/ERS 2019 Spirometry Update Task Force, joins Trial Better to define the purpose and implications of the guidance as well as its applications in clinical trials.

ERT’s Jason Eger and Phil Lake discuss clinical research industry trends and outlooks for respiratory solutions.

ERT’s Jason Eger and Amit Vasanji discuss clinical research industry trends and outlooks for imaging.

ERT’s Jason Eger and Ken Faulkner discuss clinical research industry trends and outlooks for eCOA.

ERT’s Jason Eger and Brian R. Smith discuss clinical research industry trends and outlooks for cardiac safety.

ERT’s Jason Eger and VPG Medical’s Jean-Philippe Couderc dive into the limitless potential and promise of passive health monitoring technologies in clinical trials.